BIZTRAC BETA
COMPANY REGISTER PROFILE
926352199 ORG. NO. 2025 ACCOUNTS 7 SECTIONS
Active UPDATED 15.06.2026
Uoppgitt

AKVI PHARMA AS

Org. no. 926352199 Limited company (AS) Bærum Incorporated 2020 Active
Ownership graph ↗
Revenue 2025 NOK 0
Operating profit NOK −10,000
Equity NOK 271,000
Incorporated 2020
Share capital NOK 30,000

Signals

1 flags
  • Driftsunderskudd 2025 Siste driftsresultat er negativt (−10k kr).

AKVI PHARMA AS is registered as a limited company in Bærum, Akershus with organisation number 926352199. The business is classified under uoppgitt (NACE 00.000). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Håndtering av legemidler/ medisinsk utstyr og utleie av konsulenttjenester.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −10,000 in operating profit.

Key figures · 2025

Revenue
NOK 0
Operating profit
NOK −10,000
Equity
NOK 271,000
Est. value
NOK 458,000

Financial health · 2025

Liquidity
0.16
Not satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
12.9%
Satisfactory
Equity as a share of total capital

Who owns AKVI PHARMA AS?

KJETIL KOLLSTAD
AKVI PHARMA AS
NOK 0 rev. · NOK −10,000 profit

AKVI PHARMA AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about AKVI PHARMA AS

Who owns AKVI PHARMA AS?

KJETIL KOLLSTAD is the largest registered owner, with 100.0%.

What is the revenue of AKVI PHARMA AS?

AKVI PHARMA AS had revenue of NOK 0 in 2025.

Who is the general manager of AKVI PHARMA AS?

Kjetil Kollstad is registered as general manager of AKVI PHARMA AS.

Where is AKVI PHARMA AS based?

AKVI PHARMA AS has its business address in Fornebu.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.